LungÕ 2026 – Virtual Global Congress on Lung Oncology
FDA Issues New Guidance on Cell and Gene Therapy Potency
L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care
Ciara Mageean, Olympic Runner and European Champion, Dies at 34 After Stage 4 Bowel Cancer
Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment
Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder
Financial Discrimination Against Cancer Survivors: Why the Right to Be Forgotten Is a Global Imperative
GDFATHER-NEO: Neoadjuvant Nivolumab + Visugromab in MIBC
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
